122 related articles for article (PubMed ID: 26169620)
1. Rethinking Prognosis and Therapy for Follicular Lymphoma.
Jacobson CA; Freedman AS
J Clin Oncol; 2015 Aug; 33(23):2489-91. PubMed ID: 26169620
[No Abstract] [Full Text] [Related]
2. Management of relapsed/refractory follicular lymphoma.
Martin P
Clin Adv Hematol Oncol; 2018 Apr; 16 Suppl 10(4):1-12. PubMed ID: 29851937
[No Abstract] [Full Text] [Related]
3. Is there a role for bortezomib combinations in the management of patients with follicular lymphoma?
Salles G
J Clin Oncol; 2011 Sep; 29(25):3349-50. PubMed ID: 21810690
[No Abstract] [Full Text] [Related]
4. Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study.
Feugier P; Brice P; Maynadié M; Franchi-Rezgui P; Hacini M; Laurent G; Suc E; Fitoussi O; Solal-Celigny P; Damaj G; Haioun C; Leconte P; Lazreg F; Boissard F; Pau D; Salles G
Leuk Lymphoma; 2018 Oct; 59(10):2485-2488. PubMed ID: 29486625
[No Abstract] [Full Text] [Related]
5. Follicular non-Hodgkin's lymphoma: the role of radiation therapy.
Mauch P
Ann Hematol; 2001; 80 Suppl 3():B63-5. PubMed ID: 11757711
[No Abstract] [Full Text] [Related]
6. Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet Needs.
Welaya K; Casulo C
Hematol Oncol Clin North Am; 2019 Aug; 33(4):627-638. PubMed ID: 31229159
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.
Lazarevic VL; Hägglund H; Remberger M; Wahlin A; Hallböök H; Juliusson G; Kimby E; Malm C; Omar H; Johansson JE
Leuk Lymphoma; 2011 Jan; 52(1):69-71. PubMed ID: 20919855
[No Abstract] [Full Text] [Related]
8. Routine use of maintenance therapy in follicular lymphoma: examine the rationale for maintenance use before uniformly adopting a strategy.
Flowers CR
Oncology (Williston Park); 2014 Sep; 28(9):787, 793. PubMed ID: 25224479
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.
Hess G; Keller U; Scholz CW; Witzens-Harig M; Atta J; Buske C; Kirschey S; Ruckes C; Medler C; van Oordt C; Klapper W; Theobald M; Dreyling M
Leukemia; 2015 Aug; 29(8):1695-701. PubMed ID: 25765545
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma.
Okosun J; McNamara C
Leuk Lymphoma; 2011 Feb; 52(2):328-30. PubMed ID: 21133729
[No Abstract] [Full Text] [Related]
11. Routine use of maintenance therapy in follicular lymphoma: the strategy is effective, raising the question, 'what is the most important measure of success in the current era?'.
Nastoupil LJ
Oncology (Williston Park); 2014 Sep; 28(9):786, 793. PubMed ID: 25224478
[No Abstract] [Full Text] [Related]
12. Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
Lerch K; Meyer AH; Stroux A; Hirt C; Keller U; Viardot A; Marks R; Schreiber S; Pezzutto A; Scholz CW
Ann Hematol; 2015 Jun; 94(6):981-8. PubMed ID: 25645656
[TBL] [Abstract][Full Text] [Related]
13. Role of endosonography in rectal lymphoma.
Gavioli M; Bagni A; Garoia C; Piccagli I; Biscardi A; Natalini G
Haematologica; 2000 Aug; 85(8):882-3. PubMed ID: 10942946
[No Abstract] [Full Text] [Related]
14. The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
Mozas P; Sorigué M; Rivas-Delgado A; Rivero A; Correa JG; Castillo C; Nadeu F; Bataller A; Giné E; Baumann T; Delgado J; Villamor N; Campo E; Magnano L; Sancho JM; López-Guillermo A
Eur J Haematol; 2021 Mar; 106(3):428-432. PubMed ID: 33247499
[No Abstract] [Full Text] [Related]
15. Prognostic significance of molecular remission in follicular lymphoma.
Dührsen U; Hüttmann A; Dürig J
J Clin Oncol; 2010 Oct; 28(30):e613; author reply e614. PubMed ID: 20713852
[No Abstract] [Full Text] [Related]
16. Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
Nowakowski GS; LaPlant B; Habermann TM; Rivera CE; Macon WR; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Klebig RR; Reeder CB; Witzig TE
Leukemia; 2011 Dec; 25(12):1877-81. PubMed ID: 21720383
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.
Ohe M; Hashino S
Korean J Intern Med; 2013 May; 28(3):377-9. PubMed ID: 23682236
[No Abstract] [Full Text] [Related]
18. [Standard therapy and research questions in follicular lymphoma].
Ishizawa K
Rinsho Ketsueki; 2012 Oct; 53(10):1624-33. PubMed ID: 23037735
[No Abstract] [Full Text] [Related]
19. Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort.
Rimsza LM; Li H; Braziel RM; Spier CM; Persky DO; Dunlap J; LeBlanc M; Bartlett N; Leonard JP; Smith SM; Press OW; Friedberg JW
Haematologica; 2018 Apr; 103(4):e151-e153. PubMed ID: 29472351
[No Abstract] [Full Text] [Related]
20. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Barr PM
Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
